SCHEMBL26343602

SCHEMBL26343602

CCCNC(=O)C1CCCN1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
LMNA P02545 1/20 0.43
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 3/20 0.42
FKBP1A P62942 3/20 0.41
GAA P10253 1/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
EPHX1 P07099 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NAAA Q02083 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12733389 1.00 NPSR1 (0.48) NPSR1CYP3A4CYP2D6LMNAKDM4E
SCHEMBL12733433 0.95 NPSR1 (0.47) NPSR1CYP3A4CYP2D6LMNAKDM4E
SCHEMBL12733387 0.90 NPSR1 (0.59) NPSR1CYP3A4CYP2D6KDM4EALDH1A1
SCHEMBL21696640 0.90 NPSR1 (0.59) NPSR1CYP3A4CYP2D6KDM4EALDH1A1
SCHEMBL12733388 0.89 NPSR1 (0.54) NPSR1FKBP1AEPHX1L3MBTL1NAAA
SCHEMBL12733395 0.87 NAAA (0.56) NPSR1KDM4EFKBP1AEPHX1NAAA
SCHEMBL17817483 0.87 NAAA (0.56) NPSR1KDM4EFKBP1AEPHX1NAAA
SCHEMBL12733386 0.87 NAAA (0.56) NPSR1KDM4EFKBP1AEPHX1NAAA
SCHEMBL12733385 0.87 NAAA (0.56) NPSR1KDM4EFKBP1AEPHX1NAAA
SCHEMBL5737180 0.86 CYP3A4 (0.47) NPSR1CYP3A4CYP2D6LMNAFKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303514-A1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2023-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303514-A1 TLR7/8 ANTAGONISTS AND USES THEREOF TLR7, TLR8, TLR9 NPSR1 1200/4885CYP3A4 3093/4885CYP2D6 2791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.